Combinations for the treatment of immunoinflammatory disorders
US7253155B2 · kind B2 · utility
4Cited by
47References
54Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2002 |
| Grant date | Aug 7, 2007 |
| Priority date | — |
| Expiry date | Oct 4, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features a method for treating a patient having an immunoinflammatory disorder, by administering to the patient (i) a tetra-substituted pyrimidopyrimidine, and (ii) a corticosteroid simultaneously or within 14 days of each other in amounts sufficient to reduce or inhibit immunoinflammation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.